Login
Toggle sidebar

Lint: phosphaturic-mesenchymal-tumor

phosphaturic-mesenchymal-tumor
Acronyms
warning

"Phosphaturic mesenchymal tumours are the cause of the vast majority of cases of tumour-induced (oncogenic) osteomalacia due to the production of fibroblast growth factor-23 (FGF-23)."

Line 1:202 · 'FGF' has no definition. Spell it out if it's unfamiliar to the audience.
Strong
warning

"T2: markedly hyperintense"

Line 20:1 · Generally, don't use bold in text: '<strong>T2</strong>'

"T1 C-: isointense to muscle unless there is intratumoral fat or cystic change 5"

Line 22:1 · Generally, don't use bold in text: '<strong>T1 C-</strong>'

"T1 C+: marked homogeneous enhancement"

Line 25:1 · Generally, don't use bold in text: '<strong>T1 C+</strong>'
Links
0
0
0
0
0
0
0
0
0